Research.Patient.info
Refractory hyperlipidemia research hub
2 indexed studies · 1 currently recruiting
- authorisedHuman Pharmacology (Phase I)- First administration to humans
Phase 1b Study of VERVE-201 in Patients with Refractory Hyperlipidemia
Researchers are looking into a new treatment for people with very high cholesterol that hasn't improved with other medicines. This early study, called VERVE-201, will help us understand if the new treatment is safe and how it works in the body for the very first time.
Netherlands - recruitingPHASE1
Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
This study is testing a new treatment, VERVE-201, for people with very high cholesterol and fats in their blood that haven't responded to other medicines. Scientists want to see if it's safe and how it affects these blood fats by altering a specific gene in the liver.
Australia · Canada · South Africa